Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 6 medicines · Historical list
CBG-MEB · 2 medicines
AIFA · 1 medicine
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
33 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Desoximetasone | United States | 0.05%, 0.25% | ointment | Marketed | Fougera Pharms |
| Desoximetasone | United States | 0.25% | spray | Marketed | Padagis Israel |
| Desoximetasone | United States | 0.05%, 0.25% | cream | Marketed | Fougera Pharms |
| Desoximetasone | United States | 0.05% | gel | Marketed | Padagis US |
| Topicort | United States | 0.05%, 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | gel | Marketed | Taro |
| Topicort | United States | 0.05%, 0.25%, 0.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ointment | Marketed | Taro |
| Topicort | United States | 0.05%, 0.25%, 0.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream | Marketed | Taro |
| Topicort | United States | 0.25% | spray | Marketed | Sun Pharma Canada |
| Topicort LP | United States | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream | Not marketed | Taro |
| Desoximetason Bipharma 2,5 mg/g, hydrofobe crème | Netherlands | Crème | Authorised | Bipharma B.V. | |
| Flubason | Italy | Emulsione cutanea | Authorised | Fidia Farmaceutici S.P.A. | |
| Desoxi Gel 0.05% | Canada | 0.05 % | Gel | Not marketed | Taropharma, A Division of Taro Pharmaceuticals INC. |
| Desoxi Cream 0.05% | Canada | 0.05 % | Cream | Not marketed | Taropharma, A Division of Taro Pharmaceuticals INC. |
| Desoxi Cream 0.25% | Canada | 0.25 % | Cream | Not marketed | Taropharma, A Division of Taro Pharmaceuticals INC. |
| Topicorte, emulsie voor cutaan gebruik 2,5 mg/g | Netherlands | Emulsie voor cutaan gebruik | Authorised | Fidia Farmaceutici S.p.A. | |
| Topicort | Canada | 0.25 % | Cream | Marketed | Bausch Health, Canada INC. |
| Topicort | Canada | 0.25 % | Ointment | Marketed | Bausch Health, Canada INC. |
| Topicort | Canada | 0.05 % | Gel | Marketed | Bausch Health, Canada INC. |
| Topicort | Canada | 0.05 % | Cream | Marketed | Bausch Health, Canada INC. |
| Dexapele | Brazil | Cancelled | Cellera Farmaceutica S.A. | ||
| Dexison Ointment 0.25% | Taiwan | 軟膏劑 | Cancelled | 庫禔科技有限公司 | |
| Esperson | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Esperson | Brazil | Cancelled | Sanofi Medley Farmacêutica Ltda. | ||
| Esperson NCombination | Brazil | Cancelled | Sanofi Medley Farmacêutica Ltda. | ||
| Esperson NCombination | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AIFA, Anvisa, CBG-MEB, FDA, Health Canada and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
